Immature ovarian teratoma, a rare neoplasm predominantly found in young women, commonly presents as a heterogenous mass with areas of calcification and contains varying degrees of immature neuroepithelial tissue.
Description
Immature ovarian teratoma is a rare malignant germ cell tumour that arises from the ovaries. Characterised by the presence of tissues resembling embryonic or foetal tissues, it represents an aberrant differentiation of pluripotent germ cells into multiple tissue types. It’s considered as the third most common germ cell tumour of the ovary and most frequently affects women in their reproductive years.
Pathogenesis
Immature ovarian teratomas originate from primordial germ cells within the ovary. These germ cells are pluripotent, capable of differentiating into tissues representing all three germ cell layers: ectoderm, mesoderm, and endoderm. However, unlike mature teratomas, immature teratomas contain predominantly immature (embryonal or foetal) tissues. The exact molecular and genetic triggers for this aberrant differentiation are not yet completely understood.
Subtypes
Immature teratomas are classified based on their grade (Grade 0-3), which is determined by the quantity and maturity of the neuroectodermal tissue present.
Epidemiology, Risk Factors & Associations
- Predominantly affects women in the first two decades of life, with a peak incidence in the early twenties.
- No specific risk factors or associations are known.
Clinical Features
- Presents typically as a unilateral pelvic mass
- May cause abdominal pain or bloating
- Associated with complications such as torsion, rupture, or malignant transformation
Complications
- Potential for metastasis, most commonly to lymph nodes, liver, and lungs.
- Risk of torsion, rupture, or haemorrhage due to the size of the tumour.
Pathological Features
Histopathology
- Macroscopic: Large, unilateral tumour, often cystic with solid areas. May contain recognisable derivatives from all three germ layers, such as hair, teeth, or bone.
- Microscopic: Presence of immature tissues, especially resembling embryonic neuroectodermal tissue.
Serology
- May show elevated levels of tumour markers like alpha-fetoprotein (AFP) and lactate dehydrogenase (LDH).
Biochemistry
- No specific biochemical markers
Radiological Features
General Features
- Characteristically demonstrates a complex, heterogenous mass, which may contain areas of fat, calcification, and cystic components.
CT
- Non-contrast: The tumour may appear as a complex, heterogenous mass with variable attenuation. Areas of calcification and fat may be evident.
- Contrast-enhanced: Enhancement of the solid components of the tumour may be observed.
MRI
- T1WI: Fat-containing components of the tumour appear hyperintense.
- T2WI: Cystic components appear hyperintense, while solid components may be hypo- to isointense.
- T1 C+: Enhancement of the solid components can be seen.
US
- B-mode: Heterogenous mass with calcifications, cystic areas, and echogenic fat may be observed.
- Colour: Internal vascularity in the solid components of the tumour may be seen.
NM
- PET FDG: Not typically used in the assessment of immature ovarian teratomas.
Grading
Immature teratomas are graded based on the presence and extent of immature neuroepithelial tissue. The grading is on a scale of 0 to 3, with Grade 0 being mature teratomas and Grades 1 to 3 indicating increasing amounts of immature tissue.
- Grade 0 – Mature teratoma, no immature neuroepithelial tissue is present.
- Grade 1 – Immature neuroepithelial tissue is present in low amounts, often less than 1 high-power field (HPF) per slide.
- Grade 2 – Immature neuroepithelial tissue is present in moderate amounts, typically between 2 and 3 HPF per slide.
- Grade 3 – Immature neuroepithelial tissue is extensive, seen in 4 or more HPF per slide.
Generally, higher-grade tumours have a worse prognosis and may require more aggressive therapy, including adjuvant chemotherapy following surgical resection.
Diagnosis
Diagnosis is based on clinical presentation, imaging findings, and elevated tumour markers, but definitive diagnosis requires histopathological confirmation following surgical resection.
Differential Diagnosis
- Mature cystic teratoma: Does not contain immature elements, more common in older women.
- Dysgerminoma: Typically presents as a homogenous solid mass without the complex, heterogenous appearance of an immature teratoma.
Management
Management typically involves surgical resection of the tumour. Depending on the stage and grade of the tumour, adjuvant chemotherapy may be required.